메뉴 건너뛰기




Volumn 115, Issue 25, 2010, Pages 5222-5231

WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; IDARUBICIN; CCAAT ENHANCER BINDING PROTEIN; CD135 ANTIGEN; CEBPA PROTEIN, HUMAN; FLT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEOPHOSMIN; WT1 PROTEIN;

EID: 77954671159     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-12-259390     Document Type: Article
Times cited : (148)

References (38)
  • 1
    • 0026016308 scopus 로고
    • Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development
    • Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol. 1991;11(3):1707-1712. (Pubitemid 21895530)
    • (1991) Molecular and Cellular Biology , vol.11 , Issue.3 , pp. 1707-1712
    • Buckler, A.J.1    Pelletier, J.2    Haber, D.A.3    Glaser, T.4    Housman, D.E.5
  • 2
    • 0031010990 scopus 로고    scopus 로고
    • Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis
    • Baird PN, Simmons PJ. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp Hematol. 1997;25(4):312-320. (Pubitemid 27236656)
    • (1997) Experimental Hematology , vol.25 , Issue.4 , pp. 312-320
    • Baird, P.N.1    Simmons, P.J.2
  • 3
    • 0035901533 scopus 로고    scopus 로고
    • The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells
    • DOI 10.1093/emboj/20.8.1897
    • Ellisen LW, Carlesso N, Cheng T, Scadden DT, Haber DA. The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells. EMBO J. 2001;20(8):1897-1909. (Pubitemid 32397392)
    • (2001) EMBO Journal , vol.20 , Issue.8 , pp. 1897-1909
    • Ellisen, L.W.1    Carlesso, N.2    Cheng, T.3    Scadden, D.T.4    Haber, D.A.5
  • 5
    • 0026751042 scopus 로고
    • Expression of the Wilms' tumor gene (WT1) in human leukemias
    • Miwa H, Beran M, Saunders GF. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia. 1992;6(5):405-409.
    • (1992) Leukemia , vol.6 , Issue.5 , pp. 405-409
    • Miwa, H.1    Beran, M.2    Saunders, G.F.3
  • 6
    • 0029921478 scopus 로고    scopus 로고
    • Mutations in the Wilms' tumor gene WT1 in leukemia
    • King-Underwood L, Renshaw J, Pritchard-Jones K. Mutations in the Wilms' tumor gene WT1 in leukemias. Blood. 1996 15;87(6):2171-2179. (Pubitemid 26086855)
    • (1996) Blood , vol.87 , Issue.6 , pp. 2171-2179
    • King-Underwood, L.1    Renshaw, J.2    Pritchard-Jones, K.3
  • 7
    • 34247579714 scopus 로고    scopus 로고
    • A tumor suppressor and oncogene: The WT1 story
    • DOI 10.1038/sj.leu.2404624, PII 2404624
    • Yang L, Han Y, Suarez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007;21(5):868-876. (Pubitemid 46672061)
    • (2007) Leukemia , vol.21 , Issue.5 , pp. 868-876
    • Yang, L.1    Han, Y.2    Saurez Saiz, F.3    Minden, M.D.4
  • 8
    • 34250784012 scopus 로고    scopus 로고
    • The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis
    • DOI 10.1017/S1462399407000336, PII S1462399407000336
    • Ariyaratana S, Loeb DM. The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis. Expert Rev Mol Med. 2007;9(14):1-17. (Pubitemid 46965072)
    • (2007) Expert Reviews in Molecular Medicine , vol.9 , Issue.14 , pp. 1-17
    • Ariyaratana, S.1    Loeb, D.M.2
  • 9
    • 0032522974 scopus 로고    scopus 로고
    • Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance
    • King-Underwood L, Pritchard-Jones K. Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood. 1998;91(8):2961-2968. (Pubitemid 28227547)
    • (1998) Blood , vol.91 , Issue.8 , pp. 2961-2968
    • King-Underwood, L.1    Pritchard-Jones, K.2
  • 10
    • 44049086446 scopus 로고    scopus 로고
    • Cooperating gene mutations in acute myeloid leukemia: A review of the literature
    • Renneville A, Roumier C, Biggio V, et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia. 2008;22(5):915-931.
    • (2008) Leukemia , vol.22 , Issue.5 , pp. 915-931
    • Renneville, A.1    Roumier, C.2    Biggio, V.3
  • 11
    • 68549132617 scopus 로고    scopus 로고
    • Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: A study from the Acute Leukemia French Association
    • Renneville A, Boissel N, Zurawski V, et al. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association. Cancer. 2009;115(16):3719-3727.
    • (2009) Cancer , vol.115 , Issue.16 , pp. 3719-3727
    • Renneville, A.1    Boissel, N.2    Zurawski, V.3
  • 12
    • 56749098118 scopus 로고    scopus 로고
    • Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party
    • Virappane P, Gale R, Hills R, et al. Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol. 2008;26(33):5429-5435.
    • (2008) J Clin Oncol , vol.26 , Issue.33 , pp. 5429-5435
    • Virappane, P.1    Gale, R.2    Hills, R.3
  • 13
    • 53749101166 scopus 로고    scopus 로고
    • Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study
    • Paschka P, Marcucci G, Ruppert AS, et al. Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol. 2008;26(28):4595-4602.
    • (2008) J Clin Oncol , vol.26 , Issue.28 , pp. 4595-4602
    • Paschka, P.1    Marcucci, G.2    Ruppert, A.S.3
  • 15
    • 67651046996 scopus 로고    scopus 로고
    • Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
    • Santamaria CM, Chillon MC, Garcia-Sanz R, et al. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia. Blood. 2009;114(1):148-152.
    • (2009) Blood , vol.114 , Issue.1 , pp. 148-152
    • Santamaria, C.M.1    Chillon, M.C.2    Garcia-Sanz, R.3
  • 16
    • 66549116716 scopus 로고    scopus 로고
    • Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: A study of the German-Austrian AML Study Group
    • Gaidzik VI, Schlenk RF, Moschny S, et al. Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group. Blood. 2009;113(19):4505-4511.
    • (2009) Blood , vol.113 , Issue.19 , pp. 4505-4511
    • Gaidzik, V.I.1    Schlenk, R.F.2    Moschny, S.3
  • 17
    • 33846230449 scopus 로고    scopus 로고
    • Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification?
    • DOI 10.1182/blood-2006-06-001149
    • Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood. 2007;109(2):431-448. (Pubitemid 46105936)
    • (2007) Blood , vol.109 , Issue.2 , pp. 431-448
    • Mrozek, K.1    Marcucci, G.2    Paschka, P.3    Whitman, S.P.4    Bloomfield, C.D.5
  • 19
    • 33645501151 scopus 로고    scopus 로고
    • Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
    • Chou WC, Tang JL, Lin LI, et al. Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res. 2006;66(6):3310-3316.
    • (2006) Cancer Res , vol.66 , Issue.6 , pp. 3310-3316
    • Chou, W.C.1    Tang, J.L.2    Lin, L.I.3
  • 20
    • 20044388101 scopus 로고    scopus 로고
    • Characterization of CEBPA mutations in acute myeloid leukemia: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells
    • Lin LI, Chen CY, Lin DT, et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin Cancer Res. 2005;11(4):1372-1379.
    • (2005) Clin Cancer Res , vol.11 , Issue.4 , pp. 1372-1379
    • Lin, L.I.1    Chen, C.Y.2    Lin, D.T.3
  • 21
    • 33744496772 scopus 로고    scopus 로고
    • Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome
    • Chen CY, Lin LI, Tang JL, et al. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome. Leukemia. 2006;20(6):1155-1158.
    • (2006) Leukemia , vol.20 , Issue.6 , pp. 1155-1158
    • Chen, C.Y.1    Lin, L.I.2    Tang, J.L.3
  • 22
    • 34848824979 scopus 로고    scopus 로고
    • RUNX1 gene mutation in primary myelodysplastic syndrome: The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
    • Chen CY, Lin LI, Tang JL, et al. RUNX1 gene mutation in primary myelodysplastic syndrome: the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. Br J Haematol. 2007;139(3):405-414.
    • (2007) Br J Haematol , vol.139 , Issue.3 , pp. 405-414
    • Chen, C.Y.1    Lin, L.I.2    Tang, J.L.3
  • 23
    • 0036169298 scopus 로고    scopus 로고
    • Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23
    • Shiah HS, Kuo YY, Tang JL, et al. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia. 2002;16(2):196-202.
    • (2002) Leukemia , vol.16 , Issue.2 , pp. 196-202
    • Shiah, H.S.1    Kuo, Y.Y.2    Tang, J.L.3
  • 24
    • 73949090504 scopus 로고    scopus 로고
    • AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
    • Tang JL, Hou HA, Chen CY, et al. AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 2009;114(26):5352-5361.
    • (2009) Blood , vol.114 , Issue.26 , pp. 5352-5361
    • Tang, J.L.1    Hou, H.A.2    Chen, C.Y.3
  • 25
    • 43749101634 scopus 로고    scopus 로고
    • Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD
    • Hou HA, Chou WC, Lin LI, et al. Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD. Leukemia. 2008;22(5):1075-1078.
    • (2008) Leukemia , vol.22 , Issue.5 , pp. 1075-1078
    • Hou, H.A.1    Chou, W.C.2    Lin, L.I.3
  • 26
    • 33750046021 scopus 로고    scopus 로고
    • A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias
    • Lin LI, Lin TC, Chou WC, Tang JL, Lin DT, Tien HF. A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias. Leukemia. 2006;20(10):1899-1903.
    • (2006) Leukemia , vol.20 , Issue.10 , pp. 1899-1903
    • Lin, L.I.1    Lin, T.C.2    Chou, W.C.3    Tang, J.L.4    Lin, D.T.5    Tien, H.F.6
  • 30
    • 68749110471 scopus 로고    scopus 로고
    • Reply to "Heterogeneity within AML with CEBPA mutations: Only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis."
    • Hou HA, Lin LI, Chen CY, Tien HF. Reply to "Heterogeneity within AML with CEBPA mutations: only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis." Br J Cancer. 2009;101(4):738-740.
    • (2009) Br J Cancer , vol.101 , Issue.4 , pp. 738-740
    • Hou, H.A.1    Lin, L.I.2    Chen, C.Y.3    Tien, H.F.4
  • 31
    • 64949122396 scopus 로고    scopus 로고
    • Heterogeneity within AML with CEBPA mutations: Only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
    • Pabst T, Eyholzer M, Fos J, Mueller BU. Heterogeneity within AML with CEBPA mutations: only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. Br J Cancer. 2009;100(8):1343-1346.
    • (2009) Br J Cancer , vol.100 , Issue.8 , pp. 1343-1346
    • Pabst, T.1    Eyholzer, M.2    Fos, J.3    Mueller, B.U.4
  • 32
    • 58149378467 scopus 로고    scopus 로고
    • Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
    • Owen CJ, Toze CL, Koochin A, et al. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy. Blood. 2008;112(12):4639-4645.
    • (2008) Blood , vol.112 , Issue.12 , pp. 4639-4645
    • Owen, C.J.1    Toze, C.L.2    Koochin, A.3
  • 33
    • 0032933499 scopus 로고    scopus 로고
    • Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies
    • DOI 10.1002/(SICI)1098-2264(199906)25:2<176::AID-GCC14>3.0.CO;2-F
    • Miyagawa K, Hayashi Y, Fukuda T, Mitani K, Hirai H, Kamiya K. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies. Genes Chromosomes Cancer. 1999;25(2):176-183. (Pubitemid 29226601)
    • (1999) Genes Chromosomes and Cancer , vol.25 , Issue.2 , pp. 176-183
    • Miyagawa, K.1    Hayashi, Y.2    Fukuda, T.3    Mitani, K.4    Hirai, H.5    Kamiya, K.6
  • 34
    • 67651096058 scopus 로고    scopus 로고
    • Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
    • Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, et al. Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood. 2009;113(23):5951-5960.
    • (2009) Blood , vol.113 , Issue.23 , pp. 5951-5960
    • Hollink, I.H.1    Van Den Heuvel-Eibrink, M.M.2    Zimmermann, M.3
  • 35
    • 0031043798 scopus 로고    scopus 로고
    • Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan
    • Huang SY, Tang JL, Liang YJ, Wang CH, Chen YC, Tien HF. Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan. Br J Haematol. 1997;96(4):682-687.
    • (1997) Br J Haematol , vol.96 , Issue.4 , pp. 682-687
    • Huang, S.Y.1    Tang, J.L.2    Liang, Y.J.3    Wang, C.H.4    Chen, Y.C.5    Tien, H.F.6
  • 36
    • 67650886013 scopus 로고    scopus 로고
    • Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
    • Chou WC, Chen CY, Hou HA, et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia. 2009;23(7):1303-1310.
    • (2009) Leukemia , vol.23 , Issue.7 , pp. 1303-1310
    • Chou, W.C.1    Chen, C.Y.2    Hou, H.A.3
  • 38
    • 48749094720 scopus 로고    scopus 로고
    • The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells
    • Kirschner KM, Hagen P, Hussels CS, Ballmaier M, Scholz H, Dame C. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells. FASEB J. 2008;22(8):2690-2701.
    • (2008) FASEB J. , vol.22 , Issue.8 , pp. 2690-2701
    • Kirschner, K.M.1    Hagen, P.2    Hussels, C.S.3    Ballmaier, M.4    Scholz, H.5    Dame, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.